1. We investigate here for the first time in primate brain the combinatorial expression of the three major functionally relevant proteins for catecholaminergic neurotransmission tyrosine hydroxylase (TH), aromatic acid acid decarboxylase (AADC), and the brain-specific isoform of the vesicular monoamine transporter, VMAT2, using highly specific antibodies and immunofluorescence with confocal microscopy to visualize combinatorial expression of these proteins.
INTRODUCTION
Tyrosine hydroxylase (TH) is a marker for dopamine, norepinephrine, and epinephrine-containing (catecholamine) neurons and endocrine cells. It is also expressed transiently, in development, in neurons and neuroendocrine cells that in adulthood no longer express TH or express it only at very low levels. Neurons that express TH transiently in the developing rat sympathetic nervous system include presumptive neuroblasts of the enteric nervous system of the gut (Cochard et al., 1978) , cholinergic sympathetic projections to sweat glands (Landis et al., 1988) , sympathetic innervation of the periosteum (Asmus et al., 2000) , and intrinsic adrenergic cardiac cells in the fetal heart (Huang et al., 2005) . Sensory and parasympathetic ganglia also express TH immunoreactivity during development (Jonakait et al., 1985) and in some cases into adulthood (Landis et al., 1987) .
Two recent trends have prompted a closer examination of the presumptive monoaminergic phenotype during development and in the adult mammalian nervous system. First, it is now recognized that persistence of expression of monoamine-related gene products into adulthood may differ dramatically among mammalian species. TH is present in adult mouse sympathetic sudomotor innervation, for instance, but is absent in the rat (Rao et al., 1994) . Second, the monoaminergic phenotype is increasingly viewed as a collection of individual monoaminergic traits that are not necessarily co-expressed in a concerted fashion in all neuronal subpopulations according to the classical understanding of monoaminergic neurotransmission. Habecker et al. have noted that while TH expression is maintained in mouse sympathetic cholinergic sudomotor neurons into adulthood, there is a developmentally regulated down-regulation of GTP cyclohydrolase (GTPCH) expression, required for synthesis of the TH co-factor tetrahydrobiopterin in these neurons (Habecker et al., 2002) . GTPCH may not be rate-limiting for catecholamine biosynthesis, especially in view of the wide range of its expression, from robust to immunohistochemically nondetectable, in neurons that nevertheless all synthesize and accumulate catecholamines (Hirayama and Kapatos, 1998) . However, mouse sudomotor neurons also fail to express the vesicular monoamine transporter VMAT2, and thus cannot package into secretory vesicles any TH-dependent catecholamines that might be synthesized in these neurons (Weihe et al., 2005) . In contrast, adult primate, including human, sudomotor neurons express in addition to cholinergic markers a full complement of noradrenergic markers (TH, aromatic amino acid decarboxylase or AADC, dopamine ß-hydroxylase or DßH, and VMAT2), and thus are likely to be fully functionally noradrenergic, as well as cholinergic (Weihe et al., 2005) . These observations may explain the primate-specific phenomenon of "noradrenergic sweating" (Mack et al., 1986) . A full complement of functional markers for cholinergic and noradrenergic transmission also occurs in vasomotor neurons of arteriovenous anastomoses in human skin (Weihe et al., 2005) . The occurrence of the dual transmitter phenotype in sudomotor and neighboring vasomotor neurons in tandem may allow fine tuning of neurotransmitter control of thermoregulation in human skin.
While TH expression seems to be transient in intrinsic neurons of the developing rodent gastrointestinal (GI) tract, the adult human upper GI tract is endowed with a major intrinsic VMAT2 expressing dopaminergic innervation (Anlauf et al., 2003) . In addition, neurons expressing TH, AADC, DßH, and VMAT2 are a unique novel feature of a major subpopulation of intrinsic parasympathetic cholinergic neurons of primate heart. In rodents, these neurons are not fully noradrenergic since, although they express TH, they lack VMAT2 expression (Weihe et al., 2005) .
The findings listed above have deepened understanding of monoaminergic trait expression, and its role in regulation of chemical coding of neurotransmission in the peripheral and central nervous systems. In general, the combinatorial expression of biogenic amine neurotransmitter traits, rather than obligate en bloc expression, offers a complex set of possibilities for regulating the functional neurotransmitter properties of the neurons that express them. Nonclassical patterns of expression of monoaminergic traits may in particular be quite widespread in the brain, with expression patterns dictated by both species and developmental stage. Interest in them is fueled by the preponderance of monoaminergic systems as targets for psychoactive therapeutic drugs, and drugs of abuse. Almost three decades ago, the mapping of TH and AADC in the brain led to identification of olfactory bulb neurons referred to as dopaminergic because they expressed TH and AADC and lacked DßH (Halasz et al., 1977) . Misu and colleagues have suggested, based on expression of TH, but not AADC, the existence in brain cardiovascular regulatory nuclei of neurons that elaborate dopa, but not dopamine, and hypothesized that these areas, including the nucleus tractus solitarius (NTS) and area postrema (AP), might function in interneuronal "dopaergic" signaling (Misu et al., 2002; Misu et al., 2003) . Ugrumov and colleagues have identified in developing rodent hypothalamus, TH-positive, AADC-negative "monoenzymatic" neurons that function to supply Ldopa to TH-negative, AADC-positive cells capable of synthesizing dopamine from L-dopa, and apparently, of packaging it for exocytotic, regulated secretion (Balan et al., 2000; Ugrumov et al., 2002; Ugrumov et al., 2004) . Mapping of monoamine plasma membrane and vesicular transporters in rodents during development has identified VMAT2- Schütz et al., 1998a,b) and plasma membrane serotonin transporter (SERT)-expressing thalamocortical projection neurons (Lebrand et al., 1996) . These are hypothesized to function by scavenging extracellular monoamines including serotonin for regulated secretion by neurons otherwise incapable of synthesizing serotonin on their own (Lebrand et al., 1996) .
The purpose of the present study was to extend those observations, limited mainly to the developing, peripheral, or rodent nervous systems, into the adult primate central nervous system, and to include the co-expression of VMAT2. Despite reports in the literature indicating that TH-positive, AADC-negative neurons exist in CNS as do TH-negative, AADC-positive (nonserotonergic, nonhistaminergic) neurons (Komori et al., 1991; Kitahama et al., 1996; Ugrumov, 1997; Ikemoto et al., 1998a,b; Kitahama et al., 1998; Balan et al., 2000; Ershov et al., 2002a,b; Misu et al., 2002; Ugrumov et al., 2002; Misu et al., 2003; Ugrumov et al., 2004; Ershov et al., 2005) , their functional status has not been fully assessed because the presence or absence of VMAT2 in these neurons was unknown.
Here, we asked first, what is the distribution of TH in the adult primate central nervous system in addition to the classical catecholaminergic pathways described almost a half-century ago and second, are there additional potential chemical phenotypes featuring TH expression in which chemical coding is not classically noradrenergic or dopaminergic. It is, we hope, an appropriate tribute to Julie Axelrod's leadership in the field of catecholaminergic chemical coding (Axelrod, 1986 ) that continued unbiased application of sensitive and specific assays for catecholamine biosynthetic enzymes (Saavedra et al., 1974) , in this case immunohistochemical, has yielded a novel "postclassical" view of neurotransmission in the mammalian CNS. We suggest based on the results presented herein that there are two additional major types of THpositive neurons in the adult central nervous system besides dopaminergic and noradrenergic neurons. One population is capable of dopamine synthesis but lacks a vesicular uptake system for its concentration and exocytotic release. A second is capable of L-dopa synthesis only, lacking both AADC for dopamine synthesis and VMAT for its vesicular uptake. The first (nonexocytotic dopaminergic) population may accumulate cytoplasmic dopamine and release it constitutively. The second (dopaergic) population may function, as postulated in the immature nervous system, to supply L-dopa to TH nonexpressing, AADC-expressing neurons capable of then synthesizing dopamine and perhaps releasing it via nonclassical secretory mechanisms.
MATERIALS AND METHODS

Tissue Processing for Immunocytochemistry
Rhesus monkey brain tissues were obtained from buffered saline-followed by buffered 4% formalin-perfused animals (three males and three females), and were immersed postfixed in Bouin Hollande. Experiments involving the use of rhesus macaques were approved by the Animal Care and Use Committee of Bioqual, Inc., an NIH-approved and Association for Assessment and Accreditation of Laboratory Animal Care-accredited research facility. All experiments were carried out using the ethical guidelines promulgated in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Rat and mouse brain tissues were obtained from animals which were perfused with buffered saline followed by perfusion with Bouin Hollande (Weihe et al., 2005) in accordance with the German Law for animal protection and approved by the Regierungspäsidium Giessen. All tissues were processed for double immunofluorescence confocal microscopy on deparaffinized sections. Adjacent sections (5-7 µm thick) were cut and deparaffinized. Antigen retrieval to increase the sensitivity of immunodetection was performed by heating the sections at 92-95
• C for 15 min in 0.01 M citrate buffer (pH 6) according to the DAKO protocol (Hamburg, Germany). Nonspecific binding sites were blocked with 5% bovine serum albumin (BSA, Serva, Heidelberg, Germany) in PBS (pH 7.45) followed by an avidin-biotin blocking step (Avidin-biotin Blocking Kit, Boehringer Ingelheim, Germany).
Antibodies
Primary antibodies included rodent and primate-specific rabbit polyclonal antisera against the vesicular monoamine transporter types 1 and 2 (VMAT1, VMAT2) that recognize rat and primate VMAT2 (Weihe et al., 1994; Erickson et al., 1996; Weihe et al., 1998) , mouse VMAT1 and VMAT2 (Weihe and Eiden, 2000) and rat, mouse, or human VMAT1 (Erickson et al., 1996; Weihe et al., 2005) . These antibodies are described and referenced in detail in a previous publication (Weihe et al., 2005) . Well-characterized commercially available rabbit and sheep polyclonal antibodies against tyrosine hydroxylase (TH) (Chemicon, Temecula, CA), aromatic amino acid decarboxylase (AADC) also referred to as dopa-decarboxylase (DDC) (Chemicon), and dopamine ß-hydroxylase (DßH) (Protos Biotech, New York) were also used as previously described (Weihe et al., 2005) . Details about controls for the specificity of immunoreactions in central nervous system tissue (Saper and Sawchenko, 2003) for the antisera employed in this study have been summarized in detail in a recent publication from our laboratory (Weihe et al., 2005) .
Confocal Double-Immunofluorescence Microscopy
Appropriate combinations of two primary antibodies raised in different donor species were coapplied in appropriate dilutions in 1% BSA/50 mM PBS at pH 7.4 and incubation was carried out overnight at 16
• C followed by 2 h at 37
• C as described (Weihe et al., 2005) . After extensive washing with 1%BSA/PBS over 1 h, immunoreactions were visualized by appropriate species-specific secondary antibodies labeled with Alexa Fluor® 488, or Alexa Fluor® 647 (both from MoBiTec, Göttingen, Germany; dilution 1:200 in 1%BSA/PBS), and by speciesspecific biotinylated secondary antisera (Dianova, Hamburg, Germany; diluted 1:200 in 1%BSA/PBS) followed by streptavidin conjugated with Alexa Fluor® 488 or Alexa Fluor® 647 (diluted 1:200 in PBS). Biotinylated or fluorochrome-labeled secondary antibodies and streptavidin conjugated with flurorochromes were applied for 2 h at 37
• C. Sections were extensively washed in PBS followed by distilled water for 1 h before they were coverslipped with FluorSaveTM reagent (Calbiochem, Merck Biosciences, Schwalbach, Germany). Immunofluorescence staining was documented as digitized false-color images obtained with an Olympus BX50WI laser scanning microscope (Olympus Optical, Hamburg, Germany).
RESULTS
The classical staining pattern of dopaminergic (TH, AADC, and VMAT2-positive) and noradrenergic (TH, AADC, VMAT2, and DßH-positive) neurons of primate CNS is illustrated in Fig. 1 . Staining allows complete visualization of the components of each phenotype, against which neurons deficient in the expression of any of these components can be compared. The intensities of cell body, dendrite, and nerve terminal staining for TH, AADC, DßH, and VMAT2 are quite equivalent in substantia nigra for dopaminergic (Fig. 1A) and locus coeruleus for noradrenergic (Fig. 1B) neurons. Although virtually all AADC and VMAT2-positive soma of substantia nigra are dopaminergic (i.e., also TH-positive), TH-negative, VMAT2-positive nerve terminals are observed in substantia nigra. These are more plentiful in the striatum, the target nucleus of the dopaminergic projection neurons of the Fig. 1 . Coexpression of VMAT2 and catecholamine synthesizing enzymes in classical catecholaminergic cell groups of rhesus monkey brain. Each horizontal panel (row) represents a single co-stained section analyzed by confocal microscopy. (A) Dopaminergic TH-positive neurons and processes of the substantia nigra pars compacta co-stain for AADC and VMAT2 (arrow heads). Note that VMAT2 staining in neuronal processes and fibers is comparatively weak and absent from some TH-positive fiber profiles. VMAT2-immunoreactivity appears granular and is asymmetrically concentrated in the perinuclear space while TH-positive staining comprises the entire cell bodies (lower panel). Note VMAT2-positive varicose fiber profiles lacking TH (arrows in lower panel). Bars are 30 µm. (B) Noradrenergic TH-positive neurons and processes of the locus coeruleus co-stain for AADC, DBH, and VMAT2 (arrow heads). Note two small AADC-positive cell profiles that lack TH (arrows). VMAT2-positive/THnegative puncta are intermingled between TH-positive/VMAT2-positive neuronal cell bodies and processes (high magnification in lower panel). The VMAT2-positive/TH-negative puncta presumably represent serotonergic input. The upper three panels are adjacent sections showing the same blood vessel (asterisks). Note staining of portions or all of the region of the nucleus in some AADC-positive cells, which can be attributed to superimposition of positive staining in cytoplasm underlying or overlaying the nucleus in these 7-10 µm sections. Bars are 30 µm. nigra, and are most likely to be serotonergic. TH-negative neurons immunoreactive for AADC are observed in locus coeruleus. In the absence of triple-staining for these very rare neurons, it is as yet unclear whether AADC-positive, TH-negative neurons express VMAT2.
TH-positive, AADC-positive neurons of rhesus monkey olfactory bulb are depicted in Fig. 2 . Sections are clearly and specifically positive for sparse VMAT2 nerve terminals, presumably originating from serotonergic, histaminergic, or nonclassical TH-negative neurons, as well as occasional mast cells (not shown). However, neurons of the primate olfactory bulb itself are uniformly negative for VMAT2, illustrating the second category of TH-positive neurons in primate CNS (Table I) , those which are apparently dopaminergic except for the absence of VMAT2. Staining of both cell bodies and abundant fibers for TH and AADC, but not VMAT2, can be seen in olfactory bulb. This same pattern of expression (TH and AADC-positive, VMAT2-negative) is seen in mouse and rat olfactory bulb (data not shown). TH-positive neurons of olfactory bulb are reported to be ablated along with peripheral (Guillemot et al., 1993) and central (Hirsch et al., 1998) noradrenergic neurons in MASH knock-out mice. This suggests the TH-expressing olfactory bulb neuronal population is more closely related, at least in terms of requirements for bHLH transactivating protein expression during development, to central noradrenergic than to dopaminergic neurons.
TH and AADC-positive neurons that do not express VMAT2 ("nonexocytotic catecholaminergic neurons") are surprisingly abundant, and ubiquitous, in the adult primate central nervous system. In some cases, these neurons are (Fig. 3) . Both are important as integrative and relay nuclei in the central regulation of blood pressure (Andresen et al., 2001) . Figure 3A depicts immunoreactive neurons and nerve terminals of the rhesus monkey AP stained for TH, AADC, and VMAT2. VMAT2 terminals innervating the AP are both TH-positive and TH-negative, and likely represent both peripheral noradrenergic and central serotonergic innervation of this nucleus. Interspersed TH and AADC co-positive and TH-positive, AADC-negative neurons of the AP are all devoid of VMAT2. Detailed analysis of the terminals of these soma will be required to determine their targets in the brain stem and possibly other projection areas. The NTS contains in addition to TH and AADC copositive neurons lacking VMAT2, neurons without TH that express both AADC and VMAT2 and are likely serotonergic (Fig. 3B) . TH-positive, AADC-positive, VMAT2-negative neurons are also seen in NTS of the rat (data not shown). Figure 4 depicts additional "nonexocytotic" TH and AADC co-positive neurons in the rhesus striatum. These neurons are scattered throughout the striatum, and are clearly VMAT2 negative, as seen against a background of VMAT2, TH co-positive fibers of the classical dopaminergic projection to striatum from the substantia nigra. "Non-exocytotic"(minor) and "dopaergic"(major) TH-expressing neurons are also found scattered throughout primate (rhesus monkey) cortex, decreasing in frequency from frontal to occipital cortex (data not shown), and in the medial part of the dorsal motor nucleus of the vagus. TH-positive, AADC-positive neurons lacking VMAT2 extending from the lower medulla rostrally to the level of the area postrema are found (data not shown). While cortical "nonexocytotic" TH-positive neurons were not observed in the rodent, those of the dorsal motor nucleus of the vagus were seen in both rat and mouse (data not shown). Cortical "dopaergic" neurons were also found in rodent brain (data not shown).
TH-positive "dopaergic" neurons (TH-positive, AADC-negative, VMAT2-negative) are found in several other locations in the rhesus monkey brain besides cortex (Fig. 5) . In the lateral parabrachial nucleus these cells are seen within a neuropil that is both AADC and VMAT2 positive, possibly reflecting serotonergic input to this nucleus (Fig. 5A) . Likewise, clusters of "dopaergic" TH-expressing neurons are seen in the intermediolateral cell column of the thoracic spinal cord (Fig. 5B) as well as in regions lateral and dorsolateral to the central canal (not shown). Note that "dopaergic" TH-positive neurons in both parabrachial nucleus and spinal cord are relatively small compared to soma of classical monoaminergic neurons and "nonexocytotic" TH-positive cells in the CNS. "Dopaergic" THpositive neurons are also seen in rat CNS, in both habenula (Fig. 6 ) and supraoptic nucleus (Fig. 7) . In hypothalamus, a population of AADC-positive neurons that lack TH was also observed (Fig. 7) as reported by Ugrumov and colleagues in the rat (Ugrumov 1997) .
The arcuate and periventricular nuclei of the rhesus hypothalamus is also populated by "dopaergic" TH-positive neurons (Fig. 8) , and cells of this type are plentiful in the paraventricular thalamic nucleus (Fig. 9) .
DISCUSSION
We have surveyed the adult primate and rodent central nervous systems for "nonclassical" TH-positive neurons that express AADC without VMAT2 ("nonexocytotic catecholaminergic neuronxs") or neither AADC nor VMAT2 ("dopaergic" neurons). We have found nonexocytotic dopaminergic neurons in olfactory bulb, striatum, NTS and area postrema as well as cortex and the dorsal motor nucleus of the vagus. The neurotransmitter function of dopamine that would be synthesized by these cells is not clear, since accumulation of DA into secretory vesicles would presumably not occur. Constitutive dopamine release from these cells, and its potential physiological function, will require both in vivo and in vitro investigation of this novel cell population. Whether these cells are positive for the plasma membrane transporters, allowing carrier-mediated DA release, especially in the context of indirectly acting sympathomimetics such as amphetamine and phenylephrine, or even if they have a sufficient complement of GTP cyclohydrolase to synthesize DA in appreciable amounts, also remains to be investigated. Lack of storage of DA, if synthesized in these cells, might make them vulnerable to neurotoxic damage due to accumulation of DA autooxidation products. Braak et al., have identified populations of cells in dorsal vagal motor nucleus, olfactory bulb, reticular formation, and other sites, with similar neuropigmentation characteristics, that are vulnerable to Lewy body generation in early Parkinson's disease (Del Tredici et al., 2002) . It is not known if these are TH positive or if the TH-positive neurons identified in this study represent a vulnerable population by virtue of intracellular, but not intravesicular accumulation of DA and its metabolites. Enhanced vulnerability to L-dopa toxicity is seen in classical DA neurons lacking one allele of VMAT2 (Kariya et al., 2005) . One aspect of particular clinical importance is the possibility of these neurons accumulating an excess of cytosolic, and potentially toxic, dopamine in patients receiving L-dopa therapy for Parkinson's disease, potentially limiting the benefits of this treatment regimen (Carlsson, 2001) .
Several laboratories have reported on the presence of AADC-negative, THpositive neurons of the CNS. We show here that such cell groups exist in several locations in the primate CNS, in addition to the locations previously reported (Gaspar et al., 1987; Komori et al., 1991; Ikemoto et al., 1998b; Kitahama et al., 1998) , and that they do not express VMAT2. These neurons have been referred to as "dopaergic" by several groups. Ugrumov and colleagues have discussed the possibility that in rodent hypothalamus, dopaergic neurons could supply L-dopa to the nerve terminals of other neurons that possess AADC, but lack TH, as a way of allowing coupling between two types of neurons that are each "monoenzymatic" for catecholamine biosynthesis. In fact, these workers have postulated that under conditions in which true dopaminergic neurons are decreased in number, there is an increase in dopamine synthesis in these "monoenzymatic" ones (Ershov et al., 2005) . AADC-positive TH-negative as well as TH-positive, and AADC-negative neurons were indeed observed in primate hypothalamus in this study. However, both populations lack VMAT2, so that if the latter were to supply L-dopa to the former, produced DA would not be stored in secretory vesicles for regulated release. It should be noted that these neurons express neither VMAT2 nor the neuroendocrine isoform of the vesicular monoamine transporter, VMAT1 (data not shown). Although VMAT1 mRNA has been reported to be expressed in both brain and neural crest during development in the rodent (Hansson et al., 1998a,b) , we have not observed VMAT1 protein expression in adult or developing rodent or primate brain, using sensitive and specific C-terminally directed antibodies for both rodent and primate VMAT1 (Schütz et al., 1998b; Weihe and Eiden, 2000) .
Lacking VMAT expression, TH-negative, AADC-positive neurons of the hypothalamus, at least those observed in this study, are unlikely to store the dopamine they produce upon accumulation of L-dopa from neighboring "dopaergic" monoenzymatic neurons. These neurons are, however, like "nonexocytotic catecholaminergic" cells, potential targets for generation of DA during high-dose L-dopa therapy in Parkinson's disease, and thus their altered function in the brains of PD patients treated with L-dopa, especially in vital physiological regulatory areas like hypothalamus, may need to be considered. Such neurons may also, even in the absence of VMAT2, function as depots for dopamine which may be released by indirectly acting sympathomimetic drugs of abuse including amphetamine. Indeed, amphetamine is capable of sustaining nonvesicular catecholamine release in VMAT2-deficient mice sufficient to prolong life through rescue of impaired feeding behavior (Fon et al., 1997) .
Likewise, primate intrinsic striatal TH-expressing interneurons have been shown to be substantially increased in numbers after MPTP or lentiviral GDNF transfer treatment (Betarbet et al., 1997; Palfi et al., 2002 ). As we demonstrate lack of VMAT2 in these striatal neurons, they are, like the hypothalamic THpositive, AADC-positive VMAT2-negative neurons, not fully functional with respect to vesicle-regulated release of dopamine.
In addition to the possibility that TH-positive, AADC-negative, VMAT2-negative neurons are in fact functionally dopaergic, both types of TH-positive nonclassical neurons may represent developmentally immature neurons, even in the adult CNS. TH-positive, AADC-positive neurons that do not express VMAT2 may secrete dopamine in a nonvesicular manner, or represent a pool of stem cells for maturation to a different and/or DAergic DA-secreting phenotype. As mentioned above, the presence of nonclassical TH-expressing neurons in primate CNS also raises the possibility that these neurons may be sites of action of drugs of abuse or therapeutic drugs that act on plasma membrane transporters, or increased brain concentrations of transmitters such as serotonin that could become "neurotransmitters of opportunity" in these neurons, as suggested in rodent developing thalamocortical neurons by Gaspar and colleagues .
The existence of nonclassical TH-positive neurons in the adult primate central nervous system, in nuclei of manifest importance for endocrine and cardiovascular regulation and in areas in which adult pluripotent neuronal cells are generated or migrate to, make further examination of the properties and roles in transmission and disease of these neurons of considerable interest. In this regard, Sanchez-Gonzalez and co-workers have recently identified a putative dopaminergic neuronal circuit, i.e., neurons expressing DA, the dopamine transporter DAT, and TH, and converging on the thalamus in the primate brain (Sanchez-Gonzalez et al., 2005) . It remains to be seen if this circuit also expresses VMAT2, and releases DA classically through exocytosis from secretory granules, or lacks VMAT2, suggesting that this pathway and other neuronal cell groups already identified as "nonexocytotic" dopaminergic neurons in this report, might release DA through nonclassical modes. The origins of the TH neurons projecting to the thalamus was quite diverse, and TH neurons of diverse origins differed in their dopamine content and endowment with DAT. Interestingly, parabrachial TH neurons with projections to the thalamus lacked DAT (Sanchez-Gonzales et al., 2005) and apparently also lack VMAT2 (this study). Amphetamine is able to rescue dopamine release from midbrain dopaminergic neurons of VMAT2-deficient mice (Fon et al., 1997) , and releases neurotransmitter from reserpine-treated synaptosomes via reversal of the plasma membrane transporter (Liang and Rutledge, 1982) , suggesting catecholamine release via efflux through plasma membrane transporter as a potential mechanism for nonexocytotic release from TH-positive, AADC-positive, VMAT2-negative (and TH-negative, AADCpositive "monoenzymatic") neurons that express DAT.
In summary, TH neurons in the CNS exhibit trait expression patterns beyond those associated with classical dopaminergic, noradrenergic, and adrenergic neurons. Specifically, the presence or absence of AADC and VMAT2, determines the TH-positive neuronal phenotypes described here, that may be dopaminergic, but without regulated vesicular secretion, and dopaergic, respectively. These neurons of primate CNS need now to be characterized with respect to expression of DAT, GTPCH, and other biogenic amine plasma membrane transporters (Hoffman et al., 1998) , for a full appreciation of their role in primate brain function.
